Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...
Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
ABC News on MSN7d
Personal vaccine may reduce risk of pancreatic cancer returning after surgery, small study findsA personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
We came across a bullish thesis on Moderna, Inc. (MRNA) on wallstreetbets Subreddit Page by YouAlwaysHaveAChoice. In this ...
COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...
CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the ...
TipRanks on MSN5d
Moderna’s 2024 Struggles: Navigating Commercial Challenges and Market Competition in the Vaccine IndustryModerna (MRNA) has disclosed a new risk, in the Sales & Marketing category. Moderna faces significant commercial challenges, particularly in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback